Evidence map›Paper›PMID 18310262›Full record

Trial reportBMJ (Clinical research ed.)2008

Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).

Brendan C Delaney, Michelle Qume, Paul Moayyedi, Richard F A Logan, Alexander C Ford, Cathy Elliott, Cliodna McNulty, Sue Wilson, F D Richard Hobbs

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 7 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 7 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. First regional consensus on the management ofWorld journal of gastroenterology · 2025
    Guideline
  2. Pooled it
  3. Proton pump inhibitors for functional dyspepsia.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. ACG and CAG Clinical Guideline: Management of Dyspepsia.The American journal of gastroenterology · 2017
    Guideline
  5. Proton pump inhibitors for functional dyspepsia.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Pooled it
  7. Guideline
  8. Trial
  9. Article
  10. Article
  11. Cost-effectiveness of adding aEnvironmental and occupational health practice · 2023
    Article
  12. Review
  13. Review
  14. Point-of-careThe British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Brendan C DelaneyPrimary Care Clinical Sciences, University of Birmingham, Birmingham B15 2TT. b.c.delaney@bham.ac.uk
Michelle Qume
Paul Moayyedi
Richard F A Logan
Alexander C Ford
Cathy Elliott
Cliodna McNulty
Sue Wilson
F D Richard Hobbs
University of Birmingham · GBUniversity of Nottingham · GBHealth Protection Agency · MVLeeds General Infirmary · GBMcMaster University · CA

Funding

Medical Research Council G0001078Medical Research Council MC_U122797164
6 · The paper itself

Abstract

objectiveTo determine the cost effectiveness of Helicobacter pylori "test and treat" compared with empirical acid suppression in the initial management of patients with dyspepsia in primary care.

designRandomised controlled trial.

setting80 general practices in the United Kingdom.

participants699 patients aged 18-65 who presented to their general practitioner with epigastric pain, heartburn, or both without "alarm symptoms" for malignancy.

interventionH pylori 13C urea breath test plus one week of eradication treatment if positive or proton pump inhibitor alone; subsequent management at general practitioner's discretion.

main outcome measuresCost effectiveness in cost per quality adjusted life year (QALY) (EQ-5D) and effect on dyspeptic symptoms at one year measured with short form Leeds dyspepsia questionnaire.

results343 patients were randomised to testing for H pylori, and 100 were positive. The successful eradication rate was 78%. 356 patients received proton pump inhibitor for 28 days. At 12 months no significant differences existed between the two groups in QALYs, costs, or dyspeptic symptoms. Minor reductions in costly resource use over the year in the test and treat group "paid back" the initial cost of the intervention.

conclusionsTest and treat and acid suppression are equally cost effective in the initial management of dyspepsia. Empirical acid suppression is an appropriate initial strategy. As costs are similar overall, general practitioners should discuss with patients at which point to consider H pylori testing.

trial registrationCurrent Controlled Trials ISRCTN87644265.

Indexed as

AdolescentAdultAgedCost-Benefit AnalysisDyspepsiaFamily PracticeFemaleHelicobacter InfectionsHelicobacter pyloriHumansMaleMiddle AgedProton Pump InhibitorsQuality-Adjusted Life YearsQuality of LifeSurveys and QuestionnairesProton Pump Inhibitors

Identifiers

PMID18310262
PMCPMC2270968
OpenAlexW2085500228

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.